Prevalence of metabolic syndrome and its components in patients with acute coronary syndrome;Prevalencia del síndrome metabólico y de sus componentes en pacientes con síndrome coronario agudo

Revista Espanola de Cardiologia

Volumn 64, Issue 7, 2011, Pages 579-586

  Jover, Ana ^a   Corbella, Emili ^b   Muñoz, Anna ^c   Millán, Jesús ^d   Pintó, Xavier ^b   Mangas, Alipio ^e   Zúñiga, Manuel ^f   Pedro Botet, Juan ^g   Hernández Mijares, Antonio ^a,h  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c ABBOTT LABORATORIES   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g HOSPITAL DEL MAR   (Spain)

^h UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Coronary disease; Diabetes mellitus; High density lipoproteins; Metabolic syndrome X; Obesity

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ARTICLE; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; SEX DIFFERENCE; TERTIARY HEALTH CARE;

ACUTE CORONARY SYNDROME; AGE FACTORS; AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEDENTARY LIFESTYLE; SEX FACTORS; SMOKING; SPAIN;

EID: 79959373650     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.03.010     Document Type: Article

References (50)

1. D.E. Laaksonen, H.M. Lakka, L.K. Niskanen, G.A. Kaplan, J.T. Salonen, and T.A. Lakka Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study Am J Epidemiol 156 2002 1070 1077 (Pubitemid 35396938)
2. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752 (Pubitemid 41532612)
3. A.J. Hanley, A. Festa, R.B. D'Agostino Jr., L.E. Wagenknecht, P.J. Savage, and R.P. Tracy Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity Diabetes 53 2004 1773 1781 (Pubitemid 38857035)
4. R.S. Lindsay, and B.V. Howard Cardiovascular risk associated with the metabolic syndrome Curr Diab Rep 4 2004 63 68 (Pubitemid 39359512)
5. M.P. Stern, K. Williams, C. González-Villalpando, K.J. Hunt, and S.M. Haffner Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27 2004 2676 2681 (Pubitemid 39441469)
6. K.G. Alberti, P. Zimmet, and J. Shaw The metabolic syndrome: a new worldwide definition Lancet 366 2005 1059 1062 (Pubitemid 41338752)
7. A. Mente, S. Yusuf, S. Islam, M.J. McQueen, S. Tanomsup, and C.L. Onen Metabolic syndrome and risk of acute myocardial infarction. A case-control study of 26,903 subjects from 52 countries J Am Coll Cardiol 55 2010 2390 2398
8. B.C. Solymoss, M.G. Bourassa, L. Campeau, A. Sniderman, M. Marcil, and J. Lespérance Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity Am J Cardiol 93 2004 159 164 (Pubitemid 38058723)
9. H.M. Lakka, D.E. Laaksonen, T.A. Lakka, L.K. Niskanen, E. Kumpusalo, and J. Tuomilehto The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716 (Pubitemid 35403784)
10. N. Sattar, A. Gaw, O. Scherbakova, I. Ford, D. O'Reilly, and S.M. Haffner Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study Circulation 108 2003 414 419 (Pubitemid 36935533)
11. S. Malik, N.D. Wong, S.S. Franklin, T.V. Kamath, G.J. L'Italien, and J.R. Pio Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults Circulation 110 2004 1245 1250 (Pubitemid 39202340)
12. J. Stamler, O. Vaccaro, J.D. Neaton, and D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial Diabetes Care 16 1993 434 444 (Pubitemid 23046633)
13. E.H. Chung, P.J. Curran, S. Sivasankaran, M.S. Chauhan, D.E. Gossman, and C.T. Pyne Prevalence of metabolic syndrome in patients ≥ 45 years of age with acute myocardial infarction having percutaneous coronary intervention Am J Cardiol 100 2007 1052 1055 (Pubitemid 47404459)
14. A. Hernández Mijares, C. Riera Fortuny, E. Solá Izquierdo, M.J. Oliver Oliver, M.L. Martínez Triguero, and C. Morillas Ariño Prevalencia del síndrome metabólico entre pacientes con cardiopatía isquémica Med Clin (Barc) 121 2003 204 208 (Pubitemid 36974785)
15. S.M. Haffner, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234 (Pubitemid 28350165)
16. S.H. Saydah, M.S. Eberhardt, C.M. Loria, and F.L. Brancati Age and the burden of death attributable to diabetes in the United States Am J Epidemiol 156 2002 714 719 (Pubitemid 35155177)
17. B. Balkau, and M.A. Charles Comment on the provisional report from the WHO consultation. European Group for the study of insulin resistance (EGIR) Diabet Med 16 1999 442 443
18. D. Einhorn, G.M. Reaven, R.H. Cobin, E. Ford, O.P. Ganda, and Y. Handelsman American College of Endocrinology position statement on the insulin resistance syndrome Endocr Pract 9 2003 237 252
19. The Joint European Society of Cardiology/American College of Cardiology Committee Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction Eur Heart J 21 2000 1502 1513
20. K. Thygesen, J.S. Alperts, H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction Eur Heart 28 2007 2525 2538 (Pubitemid 47616190)
21. E. Braunwald, E.M. Antman, J.W. Beasley, R.M. Califf, M.D. Cheitlin, J.S. Hochman American College of Cardiology; American Heart Association. Committee on the Management of Patients With Unstable Angina ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374
22. M.C. Ryan, H.M. Fenster Farin, F. Abbasi, and G.M. Reaven Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease Am J Cardiol 102 2008 40 46
23. M. López de la Torre, D. Bellido, A. Soto, J. Carreira, and A. Hernández Mijares Stansardisation of the waist circumference for each range of body mass index in adult outpatients attended to in Endocrinology and Nutrition Departments Nutr Hosp 25 2010 262 269
24. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JAMA 287 2002 356 359 (Pubitemid 34251969)
25. E. Alegría, A. Cordero, M. Laclaustra, A. Grima, M. León, and J.A. Casasnovas Prevalencia del síndrome metabólico en población laboral española: registro MESYAS Rev Esp Cardiol 52 2005 797 806 (Pubitemid 41131489)
26. M. León Latre, E.M. Andrés, A. Cordero, I. Pascual, C. Vispe, and M. Laclaustra Relación entre el síndrome metabólico y la mortalidad por cardiopatía isquémica en España Rev Esp Cardiol 62 2009 1469 1472
27. D. Nakatani, Y. Sakata, H. Sato, H. Mizuno, M. Shimizu, S. Suna Osaka Acute Coronary Insufficiency Study (OACIS) Group Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction Am J Cardiol 99 2007 885 889 (Pubitemid 46483273)
28. R. Zaliunas, R. Slapikas, R. Babarskiene, B. Slapikiene, D. Luksiene, and I. Milvidaite The prevalence of the metabolic syndrome components and their combinations in men and women with acute ischemic syndromes Medicina (Kaunas) 44 2008 521 528
29. S.S. Anand, S. Islam, A. Rosengren, M.G. Franzosi, K. Steyn, A.H. Yusufali INTERHEART Investigators Risk factors for myocardial infarction in women and men: insights from the INTERHEART study Eur Heart J 29 2008 932 940 (Pubitemid 351499478)
30. M. Zeller, P.G. Steg, J. Ravisy, Y. Laurent, L. Janin-Manificat, and I. L'Huillier Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction Arch Intern Med 165 2005 1192 1198 (Pubitemid 40720745)
31. M. Birhan Yilmaz, U. Guray, Y. Guray, H. Altay, B. Demirkan, and V. Caldir Metabolic syndrome is associated with extension of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes Coron Artery Dis 16 2005 287 292 (Pubitemid 41073297)
32. A.L. Blomkalns, A.Y. Chen, J.S. Hochman, E.D. Peterson, K. Trynosky, D.B. Diercks CRUSADE Investigators Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative J Am Coll Cardiol 45 2005 832 837 (Pubitemid 40347306)
33. A. El-Menyar, M. Zuabid, W. Rashed, W. Almahmeed, J. Al-Lawati, and K. Sulaiman Comparison of men and women with acute coronary syndrome in six Middle Eastern countries Am J Cardiol 104 2009 1018 1022
34. A.M. McNeill, W.D. Rosamond, C.J. Girman, S.M. Golden, M. Schmidt, and H.E. East The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities study Diabetes Care 28 2005 385 390 (Pubitemid 40170944)
35. J.Y. Kim, H.S. Mun, B.K. Lee, S.B. Yoon, E.Y. Choi, and P.K. Min Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease Yonsei Med J 51 2010 676 682
36. E. Moutzouri, A. Kei, M.S. Elisaf, and H.J. Milionis Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid Vasc Health Risk Manag 6 2010 525 539
37. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, and R. Belder Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504 (Pubitemid 38477774)
38. J. Shepherd, P. Barter, R. Carmena, P. Deedwania, J.C. Fruchart, and S. Haffner Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: The Treating to New Targets (TNT) study Diabetes Care 29 2006 1220 1226 (Pubitemid 44125913)
39. P. Deedwania, P. Barter, R. Carmena, J.C. Fruchart, S.M. Grundy, S. Haffner Treating to New Targets Investigators Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study Lancet 368 2006 919 928 (Pubitemid 44331360)
40. J.F. Ascaso, A. Fernández-Cruz, P. González Santos, A. Hernández Mijares, A. Mangas Rojas, and J. Millán Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum Am J Cardiovasc Drugs 4 2004 299 314 (Pubitemid 39429836)
41. E. Bruckert, M. Baccara-Dinet, F. McCoy, and J. Chapman High prevalence of low HDL cholesterol in a pan-European survey of 8545 dyslipidaemic patients Curr Med Res Opin 21 2005 1927 1934 (Pubitemid 41803102)
42. E. Bruckert, M. Baccara-Dinet, and E. Eschwege Low HDL cholesterol is common in European type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey Diabet Med 24 2007 388 391 (Pubitemid 46452407)
43. M.A. Austin, M.C. King, K.M. Vranizan, and R.M. Krauss Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk Circulation 82 1990 495 506 (Pubitemid 20257828)
44. G.M. Reaven, Y.D. Chen, J. Jeppesen, P. Maheux, and R.M. Krauss Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles J Clin Invest 92 1993 141 146 (Pubitemid 23208989)
45. S. Kathiresan, J.D. Otvos, L.M. Sullivan, M.J. Keyes, E.J. Schaefer, and P.W. Wilson Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study Circulation 113 2006 20 29 (Pubitemid 43958484)
46. V.G. Athyros, D.P. Mikhailidis, A.I. Kakafika, A. Karagiannis, A. Hatzitolios, and K. Tziomalos Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise CHDL levels Curr Drug Targets 8 2007 483 488 (Pubitemid 46381298)
47. P.M. Ridker, J.E. Buring, N.R. Cook, and N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women Circulation 107 2003 391 397
48. H.M. Farin, F. Abbasi, and G.M. Reaven Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals Am J Cardiol 98 2006 1053 1056 (Pubitemid 44486142)
49. S. Ahnve, B. Angelin, O. Edhag, and L. Berglund Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention J Intern Med 226 1989 297 301 (Pubitemid 19269631)
50. Y. Henkin, E. Crystal, Y. Goldberg, M. Friger, J. Lorber, and I. Zuili Usefulness of lipoprotein changes during acute coronary syndromes for predicting postdischarge lipoprotein levels Am J Cardiol 89 2002 7 11 (Pubitemid 34066578)